NCT03752905View on ClinicalTrials.gov

A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Recessive Dystrophic Epidermolysis Bullosa
Interventions
DRUG

PTR-01

Recombinant human collagen 7 (rC7)

DRUG

Normal saline

Saline control

Trial Locations (3)

19107

Thomas Jefferson Univeristiy, Philadelphia

80045

Children's Hospital Colorado, Aurora

94063

Stanford University, Redwood City

Sponsors
All Listed Sponsors
lead

Phoenix Tissue Repair, Inc.

INDUSTRY